In mice, administration of recombinant annexin A5 reduces infarct size and preserves cardiac function after myocardial ischemia/reperfusion, demonstrating a cardioprotective effect of annexin A5 (32). The gene discussed is ANXA5; the disease is myocardial ischemia.